202 related articles for article (PubMed ID: 34529130)
1. Response to letter to the editor regarding C Franzese et al. "Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer".
Franzese C; Teriaca A; De Virgilio A; Mercante G; Spriano G; Scorsetti M
J Cancer Res Clin Oncol; 2022 Apr; 148(4):1003-1004. PubMed ID: 34529130
[TBL] [Abstract][Full Text] [Related]
2. Supporting 'Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer'.
Iqbal MS; Kovarik J; Patil R; Kelly C
J Cancer Res Clin Oncol; 2022 Feb; 148(2):527-528. PubMed ID: 34351481
[No Abstract] [Full Text] [Related]
3. Response letter to the Editor of Radiotherapy and Oncology regarding the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
Karam I; Voruganti IS; Poon I
Radiother Oncol; 2022 May; 170():248-249. PubMed ID: 35278592
[No Abstract] [Full Text] [Related]
4. Letter to the editor of radiotherapy and oncology regarding of the paper "Stereotactic body radiotherapy for head and neck skin cancer" by IS Voruganti et al.
Pergolizzi S; Ferini G; Parisi S
Radiother Oncol; 2022 May; 170():247. PubMed ID: 35278593
[No Abstract] [Full Text] [Related]
5. Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy.
Tonneau M; Nebbache R; Larnaudie A; Thureau S; Pointreau Y; Blanchard P; Thariat J
Cancer Radiother; 2024 Feb; 28(1):83-92. PubMed ID: 37620212
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer.
Franzese C; Badalamenti M; Teriaca A; De Virgilio A; Mercante G; Cavina R; Ferrari D; Santoro A; Spriano G; Scorsetti M
J Cancer Res Clin Oncol; 2021 May; 147(5):1307-1313. PubMed ID: 33471186
[TBL] [Abstract][Full Text] [Related]
7. Oligometastatic head and neck cancer: Comprehensive review.
Vengaloor Thomas T; Packianathan S; Bhanat E; Albert A; Abraham A; Gordy X; Kanakamedala M; Mehta D; Vijayakumar S
Head Neck; 2020 Aug; 42(8):2194-2201. PubMed ID: 32220043
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
Bonomo P; Greto D; Desideri I; Loi M; Di Cataldo V; Orlandi E; Iacovelli NA; Becherini C; Visani L; Salvestrini V; Mariotti M; Livi L
Oral Oncol; 2019 Jun; 93():1-7. PubMed ID: 31109688
[TBL] [Abstract][Full Text] [Related]
9. Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.
Bates JE; De Leo AN; Morris CG; Amdur RJ; Dagan R
Head Neck; 2019 Jul; 41(7):2309-2314. PubMed ID: 30788878
[TBL] [Abstract][Full Text] [Related]
10. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in radiation therapy for head and neck cancer.
Bangalore M; Matthews S; Suntharalingam M
ORL J Otorhinolaryngol Relat Spec; 2007; 69(1):1-12. PubMed ID: 17085946
[TBL] [Abstract][Full Text] [Related]
12. Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Sun XS; Michel C; Babin E; De Raucourt D; Péchery A; Gherga E; Géry B; Florescu C; Bourhis J; Thariat J
Future Oncol; 2018 Apr; 14(9):877-889. PubMed ID: 29578359
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiotherapy for medically unfit patients with cancers to the head and neck.
Al-Assaf H; Erler D; Karam I; Lee JW; Higgins K; Enepekides D; Zhang L; Eskander A; Poon I
Head Neck; 2020 Aug; 42(8):2050-2057. PubMed ID: 32199031
[TBL] [Abstract][Full Text] [Related]
14. Emerging applications of stereotactic radiotherapy in head and neck cancer.
Truong MT; Grillone G; Tschoe C; Chin L; Kachnic LA; Jalisi S
Neurosurg Focus; 2009 Dec; 27(6):E11. PubMed ID: 19951054
[TBL] [Abstract][Full Text] [Related]
15. Delineation of Lingual Artery as an Additional Organ-At-Risk for Stereotactic Body Radiation Therapy of Head and Neck Cancers.
Bansal I; Singh R; Bansal K; Bansal A
Pract Radiat Oncol; 2023; 13(6):517-521. PubMed ID: 37597614
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer.
Stanisce L; Koshkareva Y; Xu Q; Patel A; Squillante C; Ahmad N; Rajagopalan K; Kubicek GJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818780086. PubMed ID: 29890894
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review.
Baliga S; Kabarriti R; Ohri N; Haynes-Lewis H; Yaparpalvi R; Kalnicki S; Garg MK
Head Neck; 2017 Mar; 39(3):595-601. PubMed ID: 27997054
[TBL] [Abstract][Full Text] [Related]
18. [Intensity-modulated radiation therapy and stereotactic body radiation therapy for head and neck tumors: evidence-based medicine].
Lapierre A; Martin F; Lapeyre M
Cancer Radiother; 2014 Oct; 18(5-6):468-72. PubMed ID: 25155467
[TBL] [Abstract][Full Text] [Related]
19. A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients.
Khalladi N; Dejean C; Bosset M; Pointreau Y; Kinj R; Racadot S; Castelli J; Huguet F; Renard S; Guihard S; Tao Y; Rouvier JM; Johnson A; Bourhis J; Xu Shan S; Thariat J
Cancer Radiother; 2021 Dec; 25(8):755-762. PubMed ID: 34565664
[TBL] [Abstract][Full Text] [Related]
20. [CyberKnife radiotherapy for head and neck cancer].
Fukuda I; Kumazaki Y; Funakoshi K; Sutani S; Ootani Y; Tukamoto N; Sekine H; Dokiya T
Brain Nerve; 2011 Mar; 63(3):209-15. PubMed ID: 21386121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
